Literature DB >> 10821653

Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles.

K Sou1, T Endo, S Takeoka, E Tsuchida.   

Abstract

The critical micelle concentrations of 1, 2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[monomethoxy poly(ethylene glycol) (5000)] (PEG-DPPE) and its distearoyl analogue (PEG-DSPE) were 70 and 9 microM, respectively, in buffer solutions ([Tris] = 20 mM, [NaCl] = 140 mM, pH 7.4) at 37 degrees C. When these PEG-lipid micelle dispersions were mixed with the dispersions of phospholipid vesicles comprised of a C16 membrane, of which the carbon number is 16, or a C18 membrane, the PEG-lipid micelles were dissociated into monomers and then spontaneously incorporated into the surface of the preformed vesicles. The incorporation rates and the enthalpy changes during incorporation were measured with an isothermal titration microcalorimeter. The incorporation rate of PEG-DPPE was faster than that of PEG-DSPE, because the dissociation rate of the PEG-DPPE micelles was faster than that of PEG-DSPE micelles. The incorporation equilibrium constant of PEG-DSPE was larger than that of PEG-DPPE due to its slow dissociation rate from the membrane, caused by the stronger hydrophobic interaction. The combination of PEG-DSPE and the C18 membrane was the most thermodynamically stabilized pair. Furthermore, the dispersion stability of the surface-modified vesicles prepared by this spontaneous incorporation was analyzed by using the critical molecular weight of the polymer for the aggregation of vesicles. The aggregation of the vesicles was successfully supressed with an increase in the molecular weight of the PEG in the PEG-lipid and its incorporation ratio.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821653     DOI: 10.1021/bc990135y

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  19 in total

Review 1.  Bone marrow-targeted liposomal carriers.

Authors:  Keitaro Sou; Beth Goins; Babatunde O Oyajobi; Bruno L Travi; William T Phillips
Journal:  Expert Opin Drug Deliv       Date:  2011-01-31       Impact factor: 6.648

2.  Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

Authors:  Okhil K Nag; Vivek R Yadav; Andria Hedrick; Vibhudutta Awasthi
Journal:  Int J Pharm       Date:  2013-02-16       Impact factor: 5.875

Review 3.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

4.  Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.

Authors:  Tamer A Elbayoumi; Vladimir P Torchilin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

5.  VIP-targeted Cytotoxic Nanomedicine for Breast Cancer.

Authors:  Aparna Dagar; Antonina Kuzmis; Israel Rubinstein; Marin Sekosan; Hayat Onyuksel
Journal:  Drug Deliv Transl Res       Date:  2012-12-01       Impact factor: 4.617

6.  Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy.

Authors:  Young Tag Ko; Claudio Falcao; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

7.  Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery.

Authors:  Young Tag Ko; Amit Kale; William C Hartner; Brigitte Papahadjopoulos-Sternberg; Vladimir P Torchilin
Journal:  J Control Release       Date:  2008-10-07       Impact factor: 9.776

8.  Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia A.

Authors:  Karthik Ramani; Vivek Purohit; Razvan Miclea; Puneet Gaitonde; Robert M Straubinger; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

9.  Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles.

Authors:  Haiqing Yin; Eun Seong Lee; Dongin Kim; Kwang Hee Lee; Kyung T Oh; You Han Bae
Journal:  J Control Release       Date:  2007-12-04       Impact factor: 9.776

10.  Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies.

Authors:  Britta Schneider; Michael Grote; Matthias John; Alexander Haas; Birgit Bramlage; Ludger M Ickenstein; Kerstin Jahn-Hofmann; Frieder Bauss; Weijun Cheng; Rebecca Croasdale; Karin Daub; Simone Dill; Eike Hoffmann; Wilma Lau; Helmut Burtscher; James L Ludtke; Silke Metz; Olaf Mundigl; Zane C Neal; Werner Scheuer; Jan Stracke; Hans Herweijer; Ulrjch Brinkmann
Journal:  Mol Ther Nucleic Acids       Date:  2012-09-18       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.